Miraziridine A: Natures blueprint towards protease class-spanning inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 4, 2004, Pages 855-857

  Schaschke, Norbert ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 GUANIDINOHEPT 2 ENOIC ACID; ASPARTIC PROTEINASE; AZIRIDINE 2,3 DICARBOXYLIC ACID; CYSTEINE PROTEINASE; HEPTANOIC ACID DERIVATIVE; MIRAZIRIDINE A; NATURAL PRODUCT; PROTEINASE INHIBITOR; SERINE PROTEINASE; STATINE; TETRAPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; DRUG ACTIVITY; DRUG DESIGN; DRUG SYNTHESIS; PROTEIN DEGRADATION; REACTION ANALYSIS;

MIRABILIS; THEONELLA;

EID: 0842302978     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.12.030     Document Type: Article

References (14)

1. Nakao Y., Fujita M., Warabi K., Matsunaga S., Fusetani N. J. Am. Chem. Soc. 122:2000;10462.
2. Martichonok V., Plouffe C., Storer A.C., Ménard R., Jones J.B. J. Med. Chem. 38:1995;3078.
3. Rich D.H., Sun E.T.O., Ulm E. J. Med. Chem. 23:1980;27.
4. Sieber P., Iselin B. Helv. Chim. Acta. 51:1968;614.
5. Wang S.-S., Merrifield R.B. Int. J. Peptide Protein Res. 1:1969;235.
6. Mori K., Iwasawa H. Tetrahedron. 36:1980;87.
7. Kemp D.S., Fotouhi N., Boyd J.G., Carey R.I., Ashton C., Hoare J. Int. J. Peptide Protein Res. 31:1988;359.
8. Wu Y., Matsueda G.R., Bernatowicz M. Synth. Commun. 23:1993;3055.
9. Fehrentz J.-A., Castro B. Synthesis. 1983;676.
10. Bastiaans H.M.M., van der Baan J.L., Ottenheijm H.C.J. J. Org. Chem. 62:1997;3880.
11. The concentration is corrected according to quantitative amino acid analysis.
12. Fujishima A., Imai Y., Nomura T., Fujisawa Y., Yamamoto Y., Sugawara T. FEBS Lett. 407:1997;47.
13. Fujinaga M., Chernaia M.M., Tarasova N.I., Mosimann S.C., James M.N.G. Protein Sci. 4:1995;960.
14. Rich D.H., Sun E.T.O. Biochem. Pharmacol. 29:1980;2205.